Choose your outcomes: From the mean to the personalized assessment of outcomes in COPD. An exploratory pragmatic survey.

[1]  N. Inui,et al.  Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease , 2015, International journal of chronic obstructive pulmonary disease.

[2]  K. Jahnz-Różyk,et al.  Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD – real-life experience from an observational study , 2015, International journal of chronic obstructive pulmonary disease.

[3]  S. Minami,et al.  Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease , 2015, International journal of chronic obstructive pulmonary disease.

[4]  N. Inui,et al.  Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease. , 2015, Pulmonary pharmacology & therapeutics.

[5]  Jennifer G. Dy,et al.  Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene. , 2014, Respiratory medicine.

[6]  P. Zarogoulidis,et al.  COPD Assessment Test: A Simple Tool to Evaluate Disease Severity and Response to Treatment , 2014, COPD.

[7]  N. Chavannes,et al.  Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study , 2014, PloS one.

[8]  S. Kon,et al.  Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. , 2014, The Lancet. Respiratory medicine.

[9]  Stephanie A. Santorico,et al.  Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema , 2014, Thorax.

[10]  H. Chrystyn,et al.  Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD. , 2014, Respiratory medicine.

[11]  M. Cazzola,et al.  Long-acting bronchodilators improve health related quality of life in patients with COPD. , 2013, Respiratory medicine.

[12]  F. Falcone,et al.  Doctor-patient relationship: a resource to improve respiratory diseases management. , 2012, European journal of internal medicine.

[13]  Edwin K Silverman,et al.  Characterisation of COPD heterogeneity in the ECLIPSE cohort , 2010, Respiratory research.

[14]  P. Jones,et al.  Development and first validation of the COPD Assessment Test , 2009, European Respiratory Journal.

[15]  Matteo Bonini,et al.  Why do doctors and patients not follow guidelines? , 2009, Current opinion in allergy and clinical immunology.

[16]  M. Decramer,et al.  Bronchodilator responsiveness in patients with COPD , 2008, European Respiratory Journal.

[17]  W. MacNee,et al.  Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE) , 2008, European Respiratory Journal.

[18]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[19]  T. Mills,et al.  Measuring Health: A Guide to Rating Scales and Questionnaires , 2006 .

[20]  S. Ventegodt,,et al.  Measurement of Quality of Life II. From the Philosophy of Life to Science , 2003, TheScientificWorldJournal.

[21]  P. Velleman,et al.  Nominal, Ordinal, Interval, and Ratio Typologies are Misleading , 1993 .

[22]  J. Hallas,et al.  Low Use and Adherence to Maintenance Medication in Chronic Obstructive Pulmonary Disease in the General Population , 2014, Journal of General Internal Medicine.

[23]  O. Skjønsberg,et al.  How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? , 2005, Respiratory medicine.